Thanks for sharing.
Ok first bad news, I am 99% convinced we will not get interim results until Q1'24. Its only 36 weeks to go for year end and we need 35 weeks from last patient first dosing which hasn't happened at time of interview. So yeah, lets all mentally prepare for it.
Again good to hear consistent msg on partnering, the deal structure is typical of a pharma deal. Now lets just hope it values us right for once.
Ann: REMAP-CAP COVID-19 Study Analysis Update, page-76
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
49.0¢ |
Change
0.040(8.89%) |
Mkt cap ! $269.6M | |||
| Open | High | Low | Value | Volume |
| 46.0¢ | 50.5¢ | 46.0¢ | $2.255M | 4.621M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100000 | 49.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 49.5¢ | 21052 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| DXB (ASX) Chart |